Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

B-Myc Activators

B-Myc Activators encompass a diverse set of chemical compounds that operate through various biochemical mechanisms to enhance the activity of B-Myc. Forskolin, through its action on adenylate cyclase, raises intracellular cAMP levels, leading to the activation of PKA, which may phosphorylate B-Myc and thus augment its role in signal transduction processes. Similarly, dibutyryl-cAMP, a stable cAMP analog, activates PKA, potentially leading to enhanced phosphorylation and activity of B-Myc. Retinoic acid and sodium butyrate, by modulating retinoid signaling and histone acetylation respectively, are believed to influence the transcriptional regulation of B-Myc, thereby enhancing its cellular function. Epigallocatechin gallate indirectly increases B-Myc activity by inhibiting kinases that would otherwise negatively regulate it, and Trichostatin A, by inhibiting histone deacetylases, may also elevate B-Myc activity by allowing for a more transcriptionally active chromatin state around the MYCBP gene.

Additional compounds, such as Phorbol 12-myristate 13-acetate (PMA) and sphingosine-1-phosphate, enhance B-Myc activity through the activation of PKC and sphingosine kinase signaling pathways, respectively, which can lead to post-translational modifications of B-Myc that increase its functionality. LY294002 and rapamycin, by inhibiting PI3K and mTOR respectively, might modulate downstream signaling cascades in a manner that allows B-Myc to play a more prominent role in cellular growth.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin activates adenylate cyclase leading to an increase in cAMP levels. Elevated cAMP activates PKA, which can phosphorylate B-Myc, enhancing its activity in cellular signaling.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid modulates retinoid signaling pathways, which can upregulate B-Myc activity through transcriptional regulation and post-translational modifications.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

This catechin inhibits kinases that negatively regulate B-Myc, thus enhancing B-Myc activity indirectly by reducing inhibitory phosphorylations.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A inhibits histone deacetylases (HDACs), which can result in a more relaxed chromatin structure around the MYCBP gene, potentially enhancing B-Myc expression.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA is a PKC activator that can enhance B-Myc activity by promoting phosphorylation events that increase its functional activity in signal transduction.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

Sphingosine-1-phosphate activates sphingosine kinase, influencing signaling pathways that could lead to the post-translational modification of B-Myc, enhancing its activity.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

Dibutyryl-cAMP, a cAMP analog, activates PKA, which subsequently could phosphorylate B-Myc, thereby enhancing its role in cellular processes.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Sodium butyrate is an HDAC inhibitor that can lead to hyperacetylation of histones near the MYCBP gene, potentially enhancing B-Myc activity through increased gene expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 inhibits PI3K, which can alter downstream signaling pathways leading to modifications in B-Myc activity by altering the cellular context in which B-Myc operates.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which can shift cellular signaling in a manner that may upregulate B-Myc activity through indirect effects on cellular growth and metabolism.